ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
January - February - March - April - May - June - July - August - September - Oktober - November - December | 2002 - 2003 - 2004 - 2005 - 2006 - 2007 - 2008 - 2009 - 2010 - 2011 - 2012 - 2013 - 2014 - 2015 - 2016 - 2017 - 2018 - 2019 - 2020 - 2021 - 2022 - 2023 - 2024 - 2025 - 2026
June 2002 - 27 products
  IP  Risperdal Consta 25 mgSet(s)98.36121.8010 %Injection suspension: Risperidonum 25 mgJanssen-Cilag AGB / SL / SOG
  IP  Risperdal Consta 37,5 mgSet(s)136.48162.6010 %Injection suspension: Risperidonum 37.5 mgJanssen-Cilag AGB / SL / SOG
  IP  Risperdal Consta 50 mgSet(s)167.17195.5010 %Injection suspension: Risperidonum 50 mgJanssen-Cilag AGB / SL / SOG
  IPCI Co-Epril30 Tablet(s)7.8817.8010 %Tablets: 2 Active AgentsSandoz
Pharmaceuticals AG
B / SL / SGG
  IPCI Co-Epril100 Tablet(s)24.5443.1010 %Tablets: 2 Active AgentsSandoz
Pharmaceuticals AG
B / SL / SGG
  IPCI Venoruton 100030 Tablet(s)18.0433.3010 %Effervescent tablets: O-(2-Hydroxyethyl)-Rutosidea 1000 mgSpirig HealthCare AGD / SLG
  IPCI Arixtra 2.5 mg/0.5 ml2 syringe(s)11.4028.8010 %Injection solution in prefilled syringe: Fondaparinuxum Natricum 2.5mg / 0.5mlViatris Pharma GmbH● B / SLG
  IPCI Arixtra 2.5 mg/0.5 ml10 syringe(s)45.5665.9510 %Injection solution in prefilled syringe: Fondaparinuxum Natricum 2.5mg / 0.5mlViatris Pharma GmbHB / SLG
  IPCI Arixtra 1.5 mg/0.3 ml10 syringe(s)19.7637.9010 %Injection solution in prefilled syringe: Fondaparinuxum Natricum 1.5mg / 0.3mlViatris Pharma GmbHB / SLG
  IPCI Arixtra 5.0 mg/0.4 ml10 syringe(s)152.02181.7510 %Injection solution in prefilled syringe: Fondaparinuxum Natricum 5mg / 0.4mlViatris Pharma GmbHB / SLG
  IPCI Arixtra 7.5 mg/0.6 ml10 syringe(s)152.02181.7510 %Injection solution in prefilled syringe: Fondaparinuxum Natricum 7.5mg / 0.6mlViatris Pharma GmbHB / SLG
  IPCI Arixtra 10 mg/0.8 ml10 syringe(s)152.02181.7510 %Injection solution in prefilled syringe: Fondaparinuxum Natricum 10mg / 0.8mlViatris Pharma GmbHB / SLG
  IPCI Lyman 40'000 Mono100 ml10.2018.8510 %Spray: Heparinum Natricum 400 UI/mlDrossapharm AGD / SLG
  IPCI Arixtra 5.0 mg/0.4 ml2 syringe(s)38.0060.00k.A.Injection solution in prefilled syringe: Fondaparinuxum Natricum 5mg / 0.4mlViatris Pharma GmbHBG
  IPCI Arixtra 7.5 mg/0.6 ml2 syringe(s)38.0060.00k.A.Injection solution in prefilled syringe: Fondaparinuxum Natricum 7.5mg / 0.6mlViatris Pharma GmbHBG
  IPCI Arixtra 10 mg/0.8 ml2 syringe(s)38.0060.00k.A.Injection solution in prefilled syringe: Fondaparinuxum Natricum 10mg / 0.8mlViatris Pharma GmbHBG
  IP V/SNeisVac-CFertigspritze(n)26.5045.25k.A.Injection suspension: Polysaccharida Neisseriae Meningitidis c (Stamm C11, De-O-Acetyliert) 10µg / 0.5mlPfizer AGBG
  IPCI Estradot 258 plaster(s)6.7416.55k.A.Transdermal patch: Estradiolum 390 µgSandoz
Pharmaceuticals AG
BG
  IPCI Estradot 2524 plaster(s)17.4135.35k.A.Transdermal patch: Estradiolum 390 µgSandoz
Pharmaceuticals AG
BG
  IPCI Estradot 37.58 plaster(s)6.7416.55k.A.Transdermal patch: Estradiolum 585 µgSandoz
Pharmaceuticals AG
BG
  IPCI Estradot 37.524 plaster(s)17.4135.35k.A.Transdermal patch: Estradiolum 585 µgSandoz
Pharmaceuticals AG
● BG
  IPCI Estradot 508 plaster(s)6.7416.55k.A.Transdermal patch: Estradiolum 780 µgSandoz
Pharmaceuticals AG
BG
  IPCI Estradot 5024 plaster(s)17.4135.35k.A.Transdermal patch: Estradiolum 780 µgSandoz
Pharmaceuticals AG
● BG
  IPCI Estradot 758 plaster(s)6.7416.55k.A.Transdermal patch: Estradiolum 1.17 mgSandoz
Pharmaceuticals AG
● BG
  IPCI Estradot 7524 plaster(s)17.4135.35k.A.Transdermal patch: Estradiolum 1.17 mgSandoz
Pharmaceuticals AG
● BG
  IPCI Estradot 1008 plaster(s)6.7416.55k.A.Transdermal patch: Estradiolum 1.56 mgSandoz
Pharmaceuticals AG
● BG
  IPCI Estradot 10024 plaster(s)17.4135.35k.A.Transdermal patch: Estradiolum 1.56 mgSandoz
Pharmaceuticals AG
● BG
 show caption
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home